Choledochal Cyst and Malignancy: A Plea for Lifelong Follow-Up
dx.doi.org shows its articles on its own site.
Read the article on dx.doi.org ↗Article · Dec 2017 · 1 min read
In brief
In brief
Choledochal cysts carry a 6-30% malignancy risk in adults, with rare cases in children. Even after surgical excision, patients face a lifelong 4% cancer risk, necessitating annual surveillance with CA19-9 and ultrasound. This review examines malignancy patterns and proposes a structured postoperative follow-up protocol.
Written by the GCMD Library team from the article.
Previous research has confirmed that patients with choledochal cyst have an elevated risk of cholangiocarcinoma and gallbladder carcinoma. Current data suggest a risk of malignancy of 6 to 30% in adults with choledochal cyst. Malignancy has also occasionally been identified in children and adolescents. Multiple factors, including the age of the patient, cyst type, histological findings, and localization, have an impact on the prognosis. Information on long-term outcomes after cyst excision is limited. However, recent data suggest a lifelong elevated risk of up to 4% of cancer development following operation. This paper presents a review of the literature on cancer in patients with choledochal cyst before and after excision. A postoperative follow-up concept that consists of annual controls of CA19–9 and abdominal ultrasound is introduced.
